174 related articles for article (PubMed ID: 7748076)
21. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
[TBL] [Abstract][Full Text] [Related]
23. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.
Gunderson CC; Dutta S; Fader AN; Maniar KP; Nasseri-Nik N; Bristow RE; Diaz-Montes TP; Palermo R; Kurman RJ
Gynecol Oncol; 2014 Jan; 132(1):33-7. PubMed ID: 24316307
[TBL] [Abstract][Full Text] [Related]
24. Endometrial hyperplasia treated by progestins.
Eichner E; Abellera M
Obstet Gynecol; 1971 Nov; 38(5):739-42. PubMed ID: 5114224
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
26. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
Williams DB; Moley KH
Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
[TBL] [Abstract][Full Text] [Related]
27. Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.
Filho AM; Barbosa IC; Maia H; Genes CC; Coutinho EM
Gynecol Endocrinol; 2007 Sep; 23(9):511-7. PubMed ID: 17943546
[TBL] [Abstract][Full Text] [Related]
28. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
[TBL] [Abstract][Full Text] [Related]
29. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
30. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
[TBL] [Abstract][Full Text] [Related]
31. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
Van Campenhout J; Choquette P; Vauclair R
Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
[TBL] [Abstract][Full Text] [Related]
32. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of endometrium associated with papillary metaplastic changes in endometrial cytopathology.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Sakurai T; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Diagn Cytopathol; 2009 Jul; 37(7):487-91. PubMed ID: 19263487
[TBL] [Abstract][Full Text] [Related]
34. Involution of PTEN-null endometrial glands with progestin therapy.
Zheng W; Baker HE; Mutter GL
Gynecol Oncol; 2004 Mar; 92(3):1008-13. PubMed ID: 14984979
[TBL] [Abstract][Full Text] [Related]
35. Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series.
Zakhour M; Cohen JG; Gibson A; Walts AE; Karimian B; Baltayan A; Aoyama C; Garcia L; Dhaliwal SK; Elashoff D; Amneus M; Walsh C
BJOG; 2017 Sep; 124(10):1576-1583. PubMed ID: 28128512
[TBL] [Abstract][Full Text] [Related]
36. Steroid receptors in normal, hyperplastic and malignant human endometria.
Vihko R; Jänne O; Kauppila A
Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
[TBL] [Abstract][Full Text] [Related]
37. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
Pérez-Medina T; Bajo J; Folgueira G; Haya J; Ortega P
Gynecol Oncol; 1999 May; 73(2):299-304. PubMed ID: 10329050
[TBL] [Abstract][Full Text] [Related]
38. Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study.
Kim SR; van der Zanden C; Ikiz H; Kuzelijevic B; Havelock J; Kwon JS
J Obstet Gynaecol Can; 2018 Mar; 40(3):328-333. PubMed ID: 28986185
[TBL] [Abstract][Full Text] [Related]
39. Progestin therapy of complex endometrial hyperplasia with and without atypia.
Reed SD; Voigt LF; Newton KM; Garcia RH; Allison HK; Epplein M; Jordan D; Swisher E; Weiss NS
Obstet Gynecol; 2009 Mar; 113(3):655-662. PubMed ID: 19300331
[TBL] [Abstract][Full Text] [Related]
40. Treatment of non-atypic endometrial hyperplasia using thermal balloon endometrial ablation therapy.
Järvelä IY; Santala M
Gynecol Obstet Invest; 2005; 59(4):202-6. PubMed ID: 15731561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
